Hyundai Motor provided new funding to the lithium-metal battery developer, which was previously backed by General Motors, SAIC Motor and Applied Materials.

The Salesforce-backed contact centre software provider is seeking $210m in series D funding, according to regulatory filings.

Intel Capital has returned to participate in Hypersonix’s series B round, which valued the data analytics software provider at $200m.

BCPG has supplied a $24m capital injection for VRB Energy, which is looking to ramp up its production capabilities for its vanadium-based batteries.

On-demand logistics provider Pickupp hiked its overall funding to $15m while SK Chemicals added to the $67m already raised by drug discovery technology producer Standigm.

UC Berkeley’s cell therapy developer has filed for an initial public offering.

The BMW, Dell and Robert Bosch-backed manufacturing services platform has added just over $44m to its initial public offering, its shares having risen 58%.

AbbVie, Novartis, Corteva and Heritage Medical Systems will have an opportunity to exit the cell therapy developer through an initial public offering.

ClalTech is set to exit the cloud infrastructure management software provider in an acquisition by HPE, which will integrate Zerto with its storage division.

Sirnaomics, which counts Walvax Bio, China Resources Group and Charoen Pokphand Group as existing investors, has raised series E funding to advance its drug development activities.